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Abstract: Three new 2-methoxy acetylenic acids (1–3) and a known derivative (4), in addition to
three new natural pyrazole alkaloids (5–7) were isolated from an Indonesian marine sponge of the
genus Cinachyrella. Compounds 5 and 6 have previously been reported as synthetic compounds.
The structures of the new compounds were established on the basis of one- and two-dimensional
NMR spectroscopy as well as by mass spectrometric data. The absolute configuration of the new
acetylenic acid derivatives (1–3) was established by ECD spectroscopy. All isolated compounds were
evaluated for their cytotoxicity against L5178Y mouse lymphoma cells. Compounds 1–4 exhibited
strong activity with an IC50 value of 0.3 µM. A plausible biosynthetic pathway for the pyrazole
metabolites 5–7 is proposed.
Keywords: natural products; marine sponge; Cinachyrella sp.; 2-methoxy acetylenic acid;
pyrazole alkaloid
1. Introduction
Marine sponges (phylum Porifera) are sessile filter feeder animals with the ability to produce
bioactive secondary metabolites as an efficient defence mechanism against predators, fouling organisms
or pathogenic microorganisms [1]. Several of these metabolites possess pronounced biological activities
in disease relevant screens and have proven to be a valuable source of novel lead compounds
in drug discovery. Prominent examples of drug leads based on marine natural products include
halichondrin B (macrocyclic polyether; lead structure of anticancer drug Halaven®), dictyodendrins
(pyrrolocarbazole derivatives; lead structures of a preclinical telomerase inhibitor), and sarcodictyin
(diterpene; lead structure of a preclinical tubulin inhibitor) from the sponges Halichondria okadai,
Dictyodendrilla verongiformis, and Sarcodictyon roseum, respectively [2].
Mar. Drugs 2017, 15, 356; doi:10.3390/md15110356 www.mdpi.com/journal/marinedrugs
Mar. Drugs 2017, 15, 356 2 of 10
Sponges of the genus Cinachyrella sp. are mostly known for the production of steroids [3] and
fatty acid metabolites, such as the 2-methoxy acetylenic acid derivative cinachylenic acid A from
C. australiensis [4], or long-chain isoprenoid fatty acids from C. schulzei [5,6]. In addition, sterols have
been used in chemotaxonomic studies of C. cavernosa [7]. Notably, enigmazole A, an unprecedented
phosphate-containing macrolide from the Papua New Guinea marine sponge C. enigmatica, has been
reported to exhibit pronounced cytotoxicity against the NCI60 human tumour cell line and to interfere
with c-Kit receptor signaling, a transmembrane glycoprotein with tyrosine kinase activity, which is
involved in the growth and development of various cancers [8].
As part of our ongoing search on bioactive secondary metabolites from marine sponges,
we investigated a specimen of Cinachyrella sp. collected at Ambon Island in Indonesia. The MeOH
extract exhibited significant activity against the murine lymphoma L5178Y cell line at a concentration
of 10 µg/mL. Chromatographic separation of the extract afforded three new (1–3) acetylenic acid
derivatives and one known (4) congener, in addition to three pyrazole alkaloids (5–7) (Figure 1). Herein,
we report the structure elucidation and cytotoxic activity of the isolated compounds and provide a
rationale for the biosynthesis of the pyrazole derivatives.
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a cluster of eleven methylene groups (δH 1.30–2.26) as well as a terminal methyl group at δH 0.90 (H3-
18). Moreover, the 1H NMR spectrum revealed signals at δH 5.46 (H-7) and 5.95 (H-6) corresponding 
to an E-configurated disubstituted double bond on the basis of the large coupling constant (3J = 15.8 
Hz), as well as a methoxy group and an oxygenated methine proton (H-2) based on their integration 
and low field resonances at δH 3.36 and 3.76, respectively (Table 1). The COSY spectrum of 1 showed 
two continuous spin systems corresponding to the fragments extending from H-2 to H-7 and from 
H2-10 to H3-18 (Figure 2). The HMBC spectrum confirmed the identified substructures and 
Figure 1. Structures of 1–7.
2. Results
2.1. inachylenic cid B (1)
inachylenic acid B (1) was obtained as yellow oil. The molecular formula was determined
as C19H32O3 on the basis of the pseudomolecular ion peak at m/z 309.2420 [M + H]+ in the
high-resolution electrospray ionization mass spectrometry (HRESIMS) spectrum indicating four
degrees of unsaturation. In the 1H NMR spectrum, the fatty acid nature of 1 was apparent from
the presence of a cluster of eleven methylene groups (δH 1.30–2.26) as well as a terminal methyl group
at δH 0.90 (H3-18). Moreover, the 1H NMR spectrum revealed signals at δH 5.46 (H-7) and 5.95 (H-6)
corresponding to an E-configurated disubstituted double bond on the basis of the large coupling
constant (3J = 15.8 Hz), as well as a methoxy group and an oxygenated methine proton (H-2) based
on their integration and low field resonances at δH 3.36 and 3.76, respectively (Table 1). The COSY
spectrum of 1 showed two continuous spin systems corresponding to the fragments extending from H-2
to H-7 and from H2-10 to H3-18 (Figure 2). The HMBC spectrum confirmed the identified substructures
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and established their connection through key 3J-correlations from H-6 and H2-10 to C-8 (δc 79.9) and
from H2-11 to C-9 (δc 89.2), denoting the presence of an alkyne group (C-8/9) in the structure of
1 (Figure 2). In addition, the correlation from H-2 and H2-3 to the ester carbonyl at δc 176.0 (C-1),
suggested a terminal carboxylic acid group being located at C-2. Likewise, the remaining methoxy
group (2-OCH3) was assigned at C-2, as confirmed by inspection of the respective HMBC correlation.
Thus, the planar structure of 1 was established as shown in Figure 1. This assignment was further
supported by EIMS, which showed fragmentation ions at m/z 178 and 263, presumably originating
from cleavage at C-5/6 and C-1/2, respectively (Figure S1-5). Hence, compound 1 was identified as a
new natural product and was named cinachylenic acid B.
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Table 1. 1H (600 MHz), 13C (150 MHz), COSY, and HMBC data of cinachylenic acid B (1) in MeOH-d4,
δ in ppm.
Position 13C, Type 1 1H, m (J in Hz) COSY HMBC
1 176.0, C - 3 - 3 - 3
2 80.9, CH 3.76, dd (7.6, 4.6) 3-H C-1/3/4/19
3 32.8, CH2 1.74, m; 1.68, m 2/4-H C-1/2/4/5
4 25.3, CH2 1.50 2 3/5-H C-2/5/6
5 33.1, CH2 2.10, br qt (7.2, 1.9) 4/6-H C-3/4/6/7
6 142.7, CH 5.95, dt (15.8, 7.1) 5/7-H C-5/8
7 111.4, CH 5.46, dt (15.8, 1.9) 6-H - 3
8 79.9, C - 3 - 3 - 3
9 89. , C - 3 - 3 - 3
10 19.6, CH2 2.26, br td (7.0, 2.1) 11-H C-7/8/9/11/12
11 29.5, CH2 1.49 2; 1.40, m 10/12-H C-9/10/13
12 29.5, CH2 1.30 2 11/13-H - 3
13 30.4, CH2 1.30 2 12/14-H - 3
14 30.4, CH2 1.30 2 13/15-H - 3
15 30.4, CH2 1.30 2 14/16-H - 3
16 32.9, CH2 1.30 2 15/17-H - 3
17 23.5, CH2 1.33 2 16/18-H C-16/18
18 14.0, CH3 0.90, t (7.0) 17-H C-16/17
19 57.9, CH3 3.36, s - 3 C-2
1 Data extracted from HMBC spectra, 2 Overlapped signals, 3 None.
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2.2. Cinachylenic Acid C (2)
Compound 2 was isolated as yellow oil. The HRESIMS exhibited the pseudomolecular ion peak at
m/z 307.2266 [M + H]+, consistent with the molecular formula C19H30O3, thus revealing five degrees
of unsaturation. The 1H NMR spectrum of 2 was similar to that of 1, apart from the replacement of
the methylene groups H2-12 and H2-13 in 1 by two olefinic protons resonating at δH 5.45 and 5.48,
respectively (Table 2). The aforementioned spectroscopic differences suggested that 2 features the
same molecular framework as 1, bearing an additional double bond (C-12/13), which is in agreement
with the 2 amu molecular weight difference observed between both compounds. This assumption
was supported by the HMBC correlations from H2-10 and H2-14 to C-12 (δc 129.8) and from H2-11 to
C-13 (δc 132.3), as well as by the COSY cross-peaks between H2-11 (δH 2.16) and H-12, and between
H2-14 (δH 2.00) and H-13 (Figure 2). In analogy to 1, the structure of 2 was further corroborated by
the EIMS fragment ion peaks at m/z 175 and 131, presumably originating from cleavage at C-5/6,
as well as at m/z 209 and 97, from cleavage at C-11/12 (Figure S2-5). In addition, the geometry of the
double bond C-12/13 was established as E based on the large coupling constant between H-12 and
H-13 (3J = 15.3 Hz). Accordingly, compound 2 was identified as a new natural product and the name
cinachylenic acid C is proposed.
Table 2. 1H (600 MHz), 13C (150 MHz), COSY, and HMBC data of cinachylenic acid C (2) in MeOH-d4,
δ in ppm.
Position 13C, Type 1 1H, m (J in Hz) COSY HMBC
1 – 2 - 3 - 3 - 3
2 80.9, CH 3.76, dd (7.6, 4.6) 3-H C-4/5/19
3 32.8, CH2 1.74, m; 1.68, m 2/4-H - 3
4 25.3, CH2 1.50, m 3/5-H C-2/5/6
5 33.1, CH2 2.10, br qt (7.3, 2.0) 4/6-H C-3/4/6/7
6 142.8, CH 5.95, dt (15.7, 7.3) 5/7-H C-8
7 111.4, CH 5.46, d (15.7) 6-H - 3
8 80.0, C - 3 - 3 - 3
9 88.6, C - 3 - 3 - 3
10 20.6, CH2 2.28, td (7.1, 2.1) 11-H C-8/9/11/12
11 32.7, CH2 2.16, br q (6.5) 10/12-H C-9/12/13
12 129.8, CH 5.45 dt (15.3, 6.5) 11/13-H - 3
13 132.3, CH 5.48 dt (15.3, 6.0) 12/14-H - 3
14 32.5, CH2 2.00, br q (6.0) 13/15-H C-12/13/16
15 30.4, CH2 1.36, m 14/16-H - 3
16 31.9, CH2 1.30, m 15/17-H C-15
17 23.3, CH2 1.33, m 16/18-H C-16
18 14.0, CH3 0.90, t (6.9) 17-H C-16/17
19 58.0, CH3 3.36, s - 3 C-2
1 Data extracted from HMBC spectra, 2 Not observed, 3 None.
2.3. Cinachylenic Acid D (3)
Compound 3 was isolated as yellow oil and shared the same molecular formula with 2 (C19H30O3),
as indicated by the pseudomolecular ion peak at m/z 307.2264 [M + H]+ in the HRESIMS. In a similar
manner to 2, the 1H NMR data of 3 showed close similarity to those of 1 apart from the presence of
an additional E-configured double-bond at C-15/16, as supported by the HMBC correlation from
H3-18 to C-16 (δC 132.9) and by the large coupling constant between H-15 and H-16 (3J = 15.3 Hz)
(Table 3). Similarly, the structure of 3 was further corroborated by the EIMS fragment ion peaks at m/z
149, 175 and 278, presumably originating from cleavage at C-7/8, C-5/6 and C-16/17, respectively
(Figure S3-5). Thus, 3 was characterized as the double-bond positional isomer of 2 and was named
cinachylenic acid D.
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Table 3. 1H (600 MHz), 13C (150 MHz), COSY, and HMBC data of cinachylenic acid D (3) in MeOH-d4,
δ in ppm.
Position 13C, Type 1 1H, m (J in Hz) COSY HMBC
1 – 2 - 4 - 4 - 4
2 81.2, CH 3.74, dd (8.1, 4.7) 3-H
3 32.6, CH2 1.74, m; 1.67, m 2/4-H C-2/4/5
4 25.4, CH2 1.50 3 3/5-H C-2/5/6
5 33.2, CH2 2.10, br qt (7.2, 1.9) 4/6-H C-3/4/6/7
6 142.8, CH 5.95, dt (15.9, 7.1) 5/7-H C-5/8
7 111.4, CH 5.46, d (15.9) 6-H - 4
8 79.8, C - 4 - 4 - 4
9 88.9, C - 4 - 4 - 4
10 19.5, CH2 2.25, td (7.0, 2.2) 11-H C-8/9/11/12
11 29.8, CH2 1.49 3 10/12-H C-9/10
12 29.1, CH2 1.30, m 11/13-H - 4
13 29.9, CH2 1.38, m 12/14-H C-14
14 30.3, CH2 1.99 3 13/15-H C-12/13
15 – 2 5.43 3 14/16-H - 4
16 132.9, CH 5.39, dt (15.3, 6.3) 15/17-H - 4
17 26.3, CH2 1.99 3 16/18-H C-18
18 14.2, CH3 0.96, t (7.5) 17-H C-16/17
19 58.0, CH3 3.36, s - 4 C-2
1 Data extracted from HMBC spectra, 2 Not observed, 3 Overlapped signals, 4 None.
2.4. Cinachylenic Acid A (4)
Compound 4 was identified as 2-methoxy-trien-8-yne-octadecanoic acid, originally reported from
the marine sponge C. australiensis, based on its NMR and HRESIMS data and by comparison with the
literature [4]. The trivial name cinachylenic acid A is proposed.
2.5. Absolute Configuration of Cinachylenic Acids A–D (1–4)
The experimental ECD spectra of 1–3 were rather weak, suggesting that these compounds were
obtained as enantiomeric mixtures. Nevertheless, their ECD spectra showed a positive Cotton effect
at around 210 nm (Figures S1-6, S2-6, and S3-6), which could be attributed to the low enantiomeric
excess of the (S) enantiomer, as previously established for 2-methoxy acetylenes and fatty acids [9].
It should be noted that the ECD spectrum of 4 was not obtained due to its rapid decomposition during
storage. However, the stereocenter C-2 in 4 was assumed to be (S) based on its specific rotation value,
which has a negative sign, similarly to those of 1–3, as well as its close biogenetic relationship with the
latter metabolites.
2.6. Cinachyrazole A (5)
Compound 5 was isolated as a white, amorphous solid. Its molecular formula was established
as C7H10N2O based on the pseudomolecular ion peak observed at m/z 139.0865 [M + H]+ in the
HRESIMS spectrum, corresponding to four degrees of unsaturation. Inspection of the 1H NMR
spectrum indicated the presence of three methyl groups at δH 3.74 (H3-7), 2.38 (H3-8), and 2.51 (H3-9),
in addition to a singlet proton at δH 9.85 (H-6) characteristic of an aldehyde group. Analysis of the
HMBC spectrum confirmed the corresponding carbon signals and revealed in addition three sp2
quaternary carbon atoms at δC 151.7 (C-3), 119.0 (C-4), and 147.1 (C-5) (Table 4). HMBC correlations
from H3-8 to C-3 and C-4, from H3-9 to C-5 and C-4, and from H3-7 to C-5 were indicative of
a 1,3,5-trimethylpyrazole ring. The remaining aldehyde group was attached to C-4 based on the
observed HMBC correlations from H-6 to C-5 and C-3 (Figure 3). This structural assignment was
further supported by the ROESY cross-peaks between H3-7 and H3-9 as well as between H-6 and
both H3-8 and H3-9. Hence, compound 5 was identified as a new natural product and was named
cinachyrazole A.
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Table 4. 1H NMR (600 MHz) and 13C NMR (150 MHz) data of 5, 6, and 7 in MeOH-d4, δ in ppm.
Position
5 6 7
1H, m 13C, Type 1 1H, m 13C, Type 1 1H, m 13C, Type 1
3 - 3 151.7, C - 3 151.2, C - 3 147.9, C
4 - 3 119.0, C - 3 110.5, C - 3 113.1, C
5 - 3 147.1, C - 3 145.7, C - 3 141.4, C
6 9.85, s 186.8, CH - 3 – 2 7.95, s 138.0, CH
7 3.74, s 35.7, CH3 3.72, s 35.8, CH3 3.73, s 35.5, CH3
8 2.38, s 12.4, CH3 2.35, s – 2 2.35, s 13.0, CH3
9 2.51, s 9.7, CH3 2.50, s 11.5, CH3 2.45, s 9.9, CH3
N′-CHO - 3 - 3 - 3 - 3 8.69, s 166.1, CH
N′-CH3 - 3 - 3 - 3 - 3 3.29, s 26.4, CH3
1 Data extracted from HMBC spectra, 2 Not observed, 3 None.
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2.7. Cinachyrazole B (6)
Compound 6 was isolated as a white, amorphous solid. Its molecular formula was determined as
C7H10N2O2, in accordance with the pseudomolecular ion peak observed at m/z 155.0814 [M + H]+
in the HRESIMS spectrum. The 1H NMR data of 6 were almost superimposable to those of 5, except
for the absence of the aldehyde group signal at δH 9.85 (H-6 in 5). This spectral difference suggested
that 6 features the same pyrazole core structure as 5, apart from the replacement of the aldehyde
group by a carboxylic acid group, which is in accordance with the 16 amu increase in the molecular
weight compared to 5 (Table 4). This assumption was further corroborated by analysis of the HMBC
spectrum of 6 (Figure 3). Accordingly, the structure of 6 was assigned and the compound was named
cinachyrazole B.
2.8. Cinachyrazole C (7)
Compound 7 was isolated as a white, amorphous solid. The HRESIMS of 7 exhibited a
pseudomolecular ion peak at m/z 195.1241 [M + H]+, consistent with the molecular formula C9H14N4O.
The 1H and 13C NMR data of 7 denoted the same pyrazole basic unit as in 5 and 6 (Table 4).
The remaining resonances included an olefinic signal at δH 7.95 (CH-6, δc 138.0), an N-methyl group
at δH 3.29 (N′-CH3, δc 26.4), and an aldehyde group at δH 8.69 (N′-CHO, δc 166.1). These signals
were indicative of the presence of an N’-formyl-N’-methyl-hydrazone moiety at C-4, as supported
by the HMBC correlations from H-6 to C-5 and C-3 and from H3-N′-CH3 to N′-CHO. In addition,
the E geometry of the double bond (C-6/N) was established based on the observed ROESY cross-peak
between H-6 and H3-N′-CH3 (Figure 3). For compound 7, the name cinachyrazole C is suggested.
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2.9. Proposed Biosynthetic Pathway for 5–7
A plausible biosynthetic pathway for the isolated pyrazole derivatives 5–7 is proposed, which
includes the linkage of an acetoacetic acid and an N-acetyl-N-methylhydrazine unit via a Schiff base
formation followed by cyclization and dehydration reactions to form 6. Subsequent reduction of the
latter followed by a Schiff base formation with an N-formyl-N-methylhydrazine unit, a natural product
originally isolated from the ascomycete fungus Gyromitra esculenta [10], would finally result in the
formation of 5 and 7, respectively (Figure 4).
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3. Discussion
Compounds 1–4 are acetylenic acid derivatives possessing a methoxy group at C-2 as well as
an acetylene group at C-8/9; however, they differ in the number and/or position of double bonds at
their aliphatic chain (Figure 1). Other examples of 2-methoxy acetylenic acids from marine sponges
include corticatic acids A–E, isolated from sponge Petrosia corticata with antifungal activity [11,12],
taurospongin A from the sponge Hippospongia sp. with inhibitory activity against DNA polymerase β
and HIV reverse transcriptase [13], as well as halicynones A and B from the sponge Haliclona sp. with
antitumor activity against the human colon tumor cell line (HCT-116) [14]. Compounds 5–7 possess an
unusual 1,3,5-trimethylpyrazole core structure. It should be noted that 5 and 6 have been previously
described as synthetic compounds and this is the first report of their isolation as natural products
(Tables S5-8 and S6-6) [15,16]. Interestingly, compound 7 bears an additional hydrazone unit, which is
rarely reported from marine invertebrates [11]. To the best of our knowledge, in addition to 7, the only
examples so far of sponge-derived compounds bearing a hydrazone unit include cinachyramine,
Mar. Drugs 2017, 15, 356 8 of 10
likewise from a marine sponge of the genus Cinachyrella [12], as well as psammaplin G, a potent
inhibitor of DNA methyltransferase, from the sponge Pseudoceratina purpurea [14].
4. Materials and Methods
4.1. General Procedures
1D and 2D NMR spectra were recorded on an AVANCE III HD 600 NMR spectrometer (Bruker,
Karlsruhe, Germany) and the chemical shifts were referenced to the solvent residual peaks. HRESIMS
and EIMS were measured on a UHR-QTOF maxi 4G (Bruker Daltonics, Bremen, Germany) or on a
Thermo Finnigan TCQ 7000 mass spectrometer (Thermo Fisher Scientific GmbH, Bremen, Germany),
respectively. UV data were recorded on a Perkin-Elmer Lambda 25 UV/vis spectrometer (Perkin-Elmer,
Waltham, MA, USA). ECD spectra were recorded with a J-810 spectropolarimeter (JASCO International
Co. Ltd, Tokyo, Japan). The HPLC analysis was carried out using a Dionex UltiMate-3400SD equipped
with a LPG-3400SD pump and a DAD 300RS photodiode array detector (Dionex Softron GmbH,
Munich, Germany). The analytical column was filled with Eurosphere-10 C18 (125 × 4 mm, L × i.d.)
(Knauer, Berlin, Germany), and the gradient consisted of 0 min (10% MeOH); 5 min (10% MeOH);
35 min (100% MeOH); 45 min (100% MeOH), with MeOH, 0.1% formic acid in H2O solvent system.
UV detection during HPLC was set at 235, 254, 280, and 340 nm. A Merck Hitachi HPLC System (UV
detector L-7400; pump L-7100; Eurosphere-100 C18, 300 mm × 8 mm, Knauer, Berlin, Germany), was
used for semipreparative HPLC with a gradient system of MeOH/H2O as mobile phase. Column
chromatography was performed using Sephadex LH-20 (GE Healthcare Europe GmbH, Freiburg,
Germany) and silica gel 60 M (0.04–0.063 mm) (Macherey-Nagel, Düren, Germany) as stationary
phases. Thin-layer chromatography (TLC) was run using pre-coated silica gel 60 F254 plates (Merck
KGaA, Darmstadt, Germany) followed by UV detection at 254 nm or after spraying the plates with
anisaldehyde reagent. Optical rotations were measured using a Jasco P-2000 polarimeter (JASCO
International Co., Ltd., Tokyo, Japan).
4.2. Sponge Material
The sponge specimen was collected by scuba at Ambon, Indonesia and was identified as
Cinachyrella sp. by Dr. Nicole de Voogd (Naturalis Biodiversity Center, Leiden, The Netherlands).
A voucher specimen was deposited at the Naturalis Biodiversity Center under the reference number
RMNH POR. 10903. The sponge specimen was preserved in a mixture of EtOH and H2O (70:30) and
stored in a freezer (−20 ◦C) prior to extraction.
4.3. Extraction and Isolation
The sponge (wet weight 400 g) was cut into small pieces. The material was exhaustively
extracted with methanol (3 × 1 L) at room temperature and concentrated under vacuum to yield
1.4 g dry crude extract. The obtained extract was submitted to liquid-liquid partitioning to afford
n-hexane, ethyl acetate and n-butanol fractions. The resulting fractions were further purified by
column chromatography on Sephadex LH-20 (MeOH as mobile phase) and/or by vacuum liquid
chromatography (VLC) using n-hexane/ethyl acetate and DCM/MeOH step gradient elution, followed
by semipreparative HPLC, in a gradient system of H2O/MeOH, to yield 1 (1 mg), 2 (1.3 mg), 3 (0.8 mg),
and 4 (1 mg) from n-hexan, as well as 5 (2.5 mg), 6 (2.0 mg), and 7 (1.0 mg) from ethyl acetate fraction.
Cinachylenic acid B (1): Yellow oil; [α]20D = −11 (c 0.1, MeOH); UV (λmax, MeOH) (log ε) 229 (4.1);
HRESIMS m/z 309.2420 [M + H]+ (calcd. for C19H33O3, 309.2424); EIMS m/z (relative intensity %) 263
(32), 178 (26); 1H and 13C NMR spectroscopic data, see Table 1.
Cinachylenic acid C (2): Yellow oil; [α]20D = −30 (c 0.1, MeOH); UV (λmax, MeOH) (log ε) 228 (4.0);
HRESIMS m/z 307.2266 [M + H]+ (calcd. for C19H31O3, 307.2268); EIMS m/z (relative intensity %) 209
(4), 175 (100), 131 (70), 97 (28); 1H and 13C NMR spectroscopic data, see Table 2.
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Cinachylenic acid D (3): Yellow oil; [α]20D = −20 (c 0.1, MeOH); UV (λmax, MeOH) (log ε) 228 (3.9);
HRESIMS m/z 307.2264 [M + H]+ (calcd. for C19H31O3, 307.2268); EIMS m/z (relative intensity %) 278
(15), 175 (12), 149 (78), 131 (17); 1H and 13C NMR spectroscopic data, see Table 3.
Cinachyrazole A (5): White, amorphous solid; UV (λmax, MeOH) (log ε) 201 (3.3), 256 (3.8);
HRESIMS m/z 139.0865 [M + H]+ (calcd. for C7H11N2O, 139.0866); 1H and 13C NMR spectroscopic
data, see Table 4.
Cinachyrazole B (6): White, amorphous solid; UV (λmax, MeOH) (log ε) 229 (3.5); HRESIMS m/z
155.0814 [M + H]+ (calcd. for C7H11N2O2 155.0815); 1H and 13C NMR spectroscopic data, see Table 4.
Cinachyrazole C (7): White, amorphous solid; UV (λmax, MeOH) (log ε) 266 (3.8), 288 (4.1);
HRESIMS m/z 195.1241 [M + H]+ (calcd. for C9H15N4O, 195.1240); 1H and 13C NMR spectroscopic
data, see Table 4.
5. Conclusions
In summary, a chemical investigation of the marine sponge Cinachyrella sp. collected in Indonesia
afforded three new acetylenic acid derivatives (1–3) and one known congener (4), in addition to three
new pyrazole alkaloids (5–7). The unusual pyrazole ring of the latter is postulated to be derived
via a Schiff base formation between an acetoacetic acid and an N-acetyl-N-methylhydrazine unit.
Notably, the acetylenic acid derivatives 1–4 showed strong inhibitory effect on the growth of L5178Y
mouse lymphoma cell line with an IC50 value of 0.3 µM. In this context, our report highlights the
metabolic potential of marine sponges of the genus Cinachyrella as a rich source of novel bioactive
secondary metabolites.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/15/11/356/
s1, Supplementary Materials including HPLC, UV, HRESIMS, EIMS, 1D and 2D NMR spectra of 1–7.
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